JAK2 mutation screening might also be a more sensitive diagnostic tool, compared to bone marrow morphology, in patients presenting with “MPN-unclassifiable (MPN-U)” phenotype or splanchnic vein thrombosis (SVT), as discussed below [54]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.